Israel adult stem cell trials – hope for ALS patients?

TEL AVIV (Reuters) – A clinical trial of ALS patients conducted by BrainStorm Cell Therapeutics shows its adult stem cell therapy is well-tolerated, appears to be safe and does not present undue risk, according to an interim safety review. Continue reading